Current Treatment Algorithm for CLL and Clinical Trial Spotlight: A Resource for Clinicians

Download this clinician resource to review the current treatment algorithm and key clinical trials in CLL.
William G. Wierda, MD, PhD
Format: Adobe Acrobat (.pdf)
File Size: 209 KB
Released: December 5, 2019

Acknowledgements

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
gianola@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

Supported by educational grants from
AstraZeneca
BeiGene, Ltd.
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Pharmacyclics, LLC

Related Content

Read expert answers to clinician questions on optimizing the care of patients with CLL in today’s practice, from Clinical Care Options (CCO)

Ian W. Flinn, MD, PhD Susan M. O'Brien, MD John Pagel Headshot John Pagel, MD, PhD Released: January 15, 2021

Expert answers to clinician questions on current challenges in managing patients with myelodysplastic syndromes (MDS), from Clinical Care Options (CCO)

Guillermo Garcia-Manero, MD Rami S. Komrokji, MD Jamile Shammo, MD, FASCP, FACP Released: January 11, 2021

Expert commentary by Lydia Scarfò, MD, providing a European perspective on key studies in CLL and lymphomas from ASH 2020 as reported by Clinical Care Options (CCO)

Lydia Scarfò, MD Released: January 4, 2021

Gain key clinical insights fast, with this short slideset from CCO on optimal management of patients with MM

Brian G.M. Durie, MD Shaji Kumar, MD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesús F. San-Miguel, MD, PhD Released: December 30, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue